HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Icosapent

HCID 446284
New reaction
Print
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
10417-94-4
Standard SMILES
CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O
InChIKey
JAZBEHYOTPTENJ-JLNKQSITSA-N
Molecular formula
C20H30O2
Average molar mass
302.5 g/mol
Monoisotopic mass
302.2245802

Overview

All-cis-5,8,11,14,17-icosapentaenoic acid is an icosapentaenoic acid having five cis-double bonds at positions 5, 8, 11, 14 and 17. It has a role as a micronutrient, an antidepressant, an antineoplastic agent, an anticholesteremic drug, a nutraceutical, a mouse metabolite, a fungal metabolite and a Daphnia galeata metabolite. It is an omega-3 fatty acid and an icosapentaenoic acid. It is a conjugate acid of an all-cis-5,8,11,14,17-icosapentaenoate.

Names & identifiers

Preferred name
Icosapent
IUPAC
(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoic acid
English name
EPA
Molecular formula
C20H30O2
Molecular weight
302.45

Names & synonyms

IcosapentEPAIcosapentoIcosapentumMiraxionEye QEye-QRopufa 70Incromega e 7010srCCRIS 3279AAN7QOV9EAUNII-AAN7QOV9EA
Show more names
EICOSAPENTAENOIC ACIDCIS-5,8,11,14,17-EICOSAPENTAENOIC ACIDEicosapentaenoicTIMNODONIC ACIDEPA (Eicosapentaenoic Acid)Eicosapentaenoic acid (EPA)5C,8C,11C,14C,17C-EICOSAPENTAENOIC ACID5,8,11,14,17-EICOSAPENTAENOIC ACIDALL CIS-5,8,11,14,17-EICOSAPENTAENOIC ACID
Icosapento [INN-Spanish]EPA 45GEPA [drug]C20:5 (n-3)(5Z,8Z,11Z,14Z,17Z)-EicosapentaenoateIcosapentum [INN-Latin]CHEBI:28364C20:5n-3,6,9,12,15

Database identifiers

CAS
10417-94-4
PubChem CID
446284
DTXSID
DTXSID9041023
ChEMBL
CHEMBL460026

Properties

Computed structural properties

XLogP
5.6
Topological polar surface area
37.3 Ų
Hydrogen bond donors
1
Hydrogen bond acceptors
2
Rotatable bonds
13
Heavy atoms
22
Formal charge
0
Complexity
398

Experimental & physicochemical properties

DrugsPharmaceuticals -> Listed in ZINC15
Lipids · 2 items

Lipids -> Unambiguous Lipids

Fatty Acyls [FA] -> Fatty Acids and Conjugates [FA01] -> Unsaturated fatty acids [FA0103]

CosmeticsEmollient; Skin conditioning
SpringerMaterials PropertiesChemical diffusion
Endocrine DisruptorsPotential endocrine disrupting compound
Physical DescriptionLiquid
Collision Cross Section · 2 items

180.9 Ų [M-H]- [CCS Type: DT; Buffer gas: N2; Sample Type: Human bronchoalveolar lavage fluid (BALF); Dataset: Unambiguous Lipids]

178.53 Ų [M-H]- [CCS Type: DT; Method: single field calibrated with Agilent tune mix (Agilent)]

Physicochemical properties

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 4 items

Danger

H314 (100%): Causes severe skin burns and eye damage [Danger Skin corrosion/irritation]

P260, P264, P280, P301+P330+P331, P302+P361+P354, P304+P340, P305+P354+P338, P316, P321, P363, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 92 reports by companies from 1 notifications to the ECHA C&L Inventory.

Hazard information

Regulatory Information5,8,11,14,17-Eicosapentaenoic acid, (5Z,8Z,11Z,14Z,17Z)-: Does not have an individual approval but may be used as a component in a product covered by a group standard. It is not approved for use as a chemical in its own right.
Hazard Classes and CategoriesSkin Corr. 1B (100%)

Safety data

F
8-10-23
PPE
Faceshields, Gloves, Goggles, type ABEK (EN14387) respirator filter
wgk
3
ridadr
UN 3265 8/PG 3
hs_code
2916190090
risk_code
34
Signal word
Danger
Symbol(GHS)
GHS02,GHS07
hazard_code
C
safety_code
26-36/37/39-45
hazard_class
8
Storage Class
10 - Combustible liquids

Chemistry & industry

Pharmacology

Pharmacodynamics · 1 item

Eicosanoids are chemical messengers derived from 20-carbon polyunsaturated fatty acids that play critical roles in immune and inflammatory responses. Both 20-carbon omega-6 fatty acids (arachidonic acid) and 20-carbon omega-3 fatty acids (EPA) can be found in cell membranes. During an inflammatory response, arachidonic acid and EPA are metabolized by enzymes known as cyclooxygenases and lipoxygenases to form eicosanoids. Increasing omega-3 fatty acid intake increases the EPA content of cell membranes and decreases the arachidonic acid content, resulting in higher proportions of eicosanoids derived from EPA. Physiologic responses to arachidonic acid-derived eicosanoids differ from responses to EPA-derived eicosanoids. In general, eicosanoids derived from EPA are less potent inducers of inflammation, blood vessel constriction, and clotting than eicosanoids derived from arachidonic acid.

Mechanism of Action · 1 item

The anti-inflammatory, antithrombotic and immunomodulatory actions of EPA is probably due to its role in eicosanoid physiology and biochemistry. Most eicosanoids are produced by the metabolism of omega-3 fatty acids, specifically, arachidonic acid. These eicosanoids, leukotriene B4 (LTB4) and thromboxane A2 (TXA2) stimulate leukocyte chemotaxis, platelet aggregation and vasoconstriction. They are thrombogenic and artherogenic. On the other hand, EPA is metabolized to leukotriene B5 (LTB5) and thromboxane A3 (TXA3), which are eicosanoids that promote vasodilation, inhibit platelet aggregation and leukocyte chemotaxis and are anti-artherogenic and anti-thrombotic. The triglyceride-lowering effect of EPA results from inhibition of lipogenesis and stimulation of fatty acid oxidation. Fatty acid oxidation of EPA occurs mainly in the mitochondria. EPA is a substrate for Prostaglandin-endoperoxide synthase 1 and 2. It also appears to affect the function and bind to the Carbohydrate responsive element binding protein (ChREBP) and to a fatty acid receptor (G-coupled receptor) known as GP40.

Metabolism/MetabolitesEicosapentaenoic acid has known human metabolites that include Juniperonic acid.
Tissue LocationsAdipose Tissue
Cellular Locations

Related reactions

32 records
New reaction record
HRID 28306 reaction equation
HRID 28306As reactant
HRID 339287 reaction equation
HRID 339287As reactant
HRID 339293 reaction equation
HRID 339293As reactant
HRID 591104 reaction equation
HRID 591104As reactant
HRID 591110 reaction equation
HRID 591110As reactant
HRID 869791 reaction equation
HRID 869791As reactant
HRID 922081 reaction equation
HRID 922081As reactant
HRID 922087 reaction equation
HRID 922087As reactant
PreviousPage 1 of 4

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
ChEBI
CHEBI:28364
UNII
AAN7QOV9EA
EC Number
600-528-7
Nikkaji
J343.473G
Melting point
54 · −54-−53 °C (lit.)
Boiling point
439 ℃ · 439℃
Density
0.94 · 0.94
refractive index
1.5 · 1.50
Flash point
93 °C · 93 °C
storage temp.
-20 °C · -20°C
solubility
Soluble in methanol
pka
4.75 · 4.75±0.10(Predicted)
form
clear liquid
color
Colorless to Light yellow to Light orange
biological source
fish oil
Sensitive
Air & Light Sensitive
Merck
14 · 14,3531
BRN
1714433 · 1714433
Stability
1 year · Stable for 1 year as supplied (unopened). After opening, EPA must be stored under inert gas at -80°C. Solutions in DMSO or ethanol should also be stored under inert gas and may be kept at -80°C for up to 2 months.
Cosmetics Ingredients Functions
SKIN CONDITIONINGSKIN CONDITIONING - EMOLLIENT
InChIKey
RRGOKSYVAZDNKR-ARJAWSKDSA-N
SMILES
CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCC(O)=O
LogP
6.232 · 6.232 (est)
FDA UNII
7 QOV9EA · AAN7QOV9EA
Comptox DTXSID
9041023 · DTXSID9041023
UNSPSC Code
85151701 · 85151701
NACRES
77 · NA.77
Symbol(GHS)
2 · GHS02,GHS07
Signal word
Danger
Hazard statements
225 · H225-H319
Precautionary statements
210 · P210-P305+P351+P338
PPE
Faceshields, Gloves, Goggles, type ABEK (EN14387) respirator filter
Hazard Codes
C
Risk Statements
34 · 34
Safety Statements
26 · 26-36/37/39-45
RIDADR
3265 · UN 3265 8/PG 3
WGK Germany
3 · 3
F
8 · 8-10-23
HazardClass
8 · 8
HS Code
2916190090 · 2916190090
Storage Class
10 · 10 - Combustible liquids
Hazard statements
H225-H319
Precautionary statements
P210-P305+P351+P338
Extracellular
Metabolite Pathwaysalpha-Linolenic acid metabolism

Uses & manufacturing

Use ClassificationCosmetics -> Emollient; Skin conditioning
Applications · 5 items

DescriptionEPA is an ω-3 fatty acid abundantly available in marine organisms. It is oxygenated by COX-1 and COX-2 at rates of about 5% and 30%, respectively, compared to arachidonic acid. EPA has been shown to offer protection against coronary heart disease, thrombosis, ischemic brain injury, scaly dermatitis, and some inflammatory diseases.

UsesImportant polyunsaturated fatty acid of the marine food chain that serves as a precursor for the prostaglandin-3 and thromboxane-3 families. It differs from arachidonic acid (the eicosatetraenoic acid that is a precursor for the prostaglandin and thromboxane-2 families) by the extra double bond between the third and fourth carbons from the “methyl end” of the molecule. Antilipemic.

Usescis-5,8,11,14,17-Eicosapentaenoic acid has been used an analytical standard for the synthesis followed by investigation of pharmacological properties of aconitine-derived lipo-alkaloids.

Usescis-5,8,11,14,17-Eicosapentaenoic acid has been used:to test pharmacologic effect on steatosis in hepatocytesas an analytical standard in Raman spectra measurements to characterize human breast cancer samplesin lipid peroxidation assay in mouse embryonic fibroblasts and in pre-treatment of cells for cell viability studies

General DescriptionEicosapentaenoic acid (cis-5,8,11,14,17), also known as EPA, is a long-chain omega-3 fatty acid. Studies suggests that EPA as well as other fatty acids can serve as biomarkers for cardiovascular disease, and nutritional and metabolic disorders. This certified solution standard is suitable for use as starting material in the preparation of linearity standards, calibrators, or controls in mass spectrometry-based EPA testing applications such as assessment of cardiovasculardisease risk and fatty acid deficiency, and detection and quantification of EPA in nutraceuticals and dietary supplements.

Upstream & downstream products

Upstream raw materials

unsaturated fatty acidFatty acid ethyl esterFISH OILUreaLight alkaline waterArachidonic acid

Downstream products

cis-5,8,11,14,17-Eicosapentaenoic acid methyl ester

Additional notes

DefinitionChEBI: An icosapentaenoic acid having five cis-double bonds at positions 5, 8, 11, 14 and 17.